Dow Jones Top Company Headlines at 1 AM ET: Anthropic to Commit 5% of Its Shares to New 'Public Benefit' Fund | How ...
Anthropic to Commit 5% of Its Shares to New 'Public Benefit' Fund
The fund could send distributions directly to populations affected by AI labor disruption.
----
How Lego Is Getting More Adults to Tinker With Their Toy Bricks
Marketing chief Julia Goldin says Lego is creating buildings sets around passions that cross demographic boundaries, such as gaming and Formula One.
----
AI Agents Trading Stocks While You Sleep? Charles Schwab's CEO Is Skeptical
Schwab CEO Rick Wurster is betting some money and investing needs require a human touch.
----
Ford Wants to Make Fun Cars Again in Europe-if Drivers Can Wait Until 2028
The automaker is leaning into its racing heritage in the region as Chinese competition craters its sales.
----
How Coke Loosened Pepsi's Grip on KFC's Soda Fountains
Former PepsiCo-owned chain switched sides after a secret showdown, replete with taste tests and discussions over strategy.
----
What Tesla's Flying Roadster Really Means for the Global Auto Race
Elon Musk's latest vision for the company's sports car has more to do with China than cold-gas rocket thrusters.
----
'Street Fighter' Kicks Its Way to Top of Busy Movie Weekend
----
SoftBank in Early Talks to Buy Allied Universal
The deal, if completed, could value the business at around $18 billion.
----
Nearly All Volume on FIFA-Linked Prediction Market Is Circular Trading
ADI Predictstreet, backed by Abu Dhabi's royal family, paid close to $150 million for advertising rights during the World Cup.
----
The Holdouts Working Around New York City's Airbnb Crackdown
A crackdown on short-term rentals drastically reduced the business. Here's how the hangers-on are making it work.
----
It's Too Late for Small Fixes at Pepsi
The problem may be bigger than a few weak brands. Pepsi needs to stop tinkering and consider more fundamental changes.
----
Hermès Is Targeting a New Emerging Market: The American Suburbs
The French brand is analyzing Zip Code data to zero in on pockets of growing U.S. affluence.
----
Novartis Scraps Another Drug Study. Why the Stock Is Holding Steady.
Novartis shelves a study for Fabhalta in patients with a serious kidney-disease complication, adding to a growing list of clinical setbacks.
(END) Dow Jones Newswires
October 19, 2026 01:15 ET (05:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
What’s Ahead for Stocks This Quarter—and Where to Invest
Are TIPS ETFs the Best Way to Fight Inflation?
33 Undervalued Stocks to Buy Before the Market Shifts Again
Where to Find Durable Dividends in Today’s Stock Market
United States